-+ 0.00%
-+ 0.00%
-+ 0.00%

Roivant CEO Matthew Gline disposes of 289,774 common shares for $8.45 million

PUBT·04/20/2026 22:27:58
Listen to the news
Roivant CEO Matthew Gline disposes of 289,774 common shares for $8.45 million
  • Roivant Sciences CEO Matthew Gline disclosed sale of 289,774 common shares on April 16, 2026.
  • Shares sold at weighted average price of USD 29.16.
  • Directly held stake fell to 16,736,116 common shares following transaction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roivant Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001635088-26-000038), on April 20, 2026, and is solely responsible for the information contained therein.